Recombinant Human ZNHIT3 protein (denatured) (His tag N-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human ZNHIT3 protein (denatured) (His tag N-Terminus) is a Human Full Length protein, in the 1 to 155 aa range, expressed in Escherichia coli, with >85%, suitable for SDS-PAGE.
대체 명칭 보기
TRIP3, ZNHIT3, Zinc finger HIT domain-containing protein 3, HNF-4a coactivator, Thyroid hormone receptor interactor 3, Thyroid receptor-interacting protein 3, TR-interacting protein 3, TRIP-3
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human ZNHIT3 protein (denatured) (His tag N-Terminus) (AB171718)
15% SDS-PAGE analysis of ab171718 (3μg).
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ZNHIT3 functions as a critical component of several cellular complexes including the chromatin remodeling complexes. These complexes modulate the structure of chromatin thereby regulating gene expression. ZNHIT3 contributes to the maintenance of chromatin state impacting transcriptional activity. Its interaction with other proteins in these complexes highlights its role in gene regulatory mechanisms. Due to its involvement in chromatin dynamics ZNHIT3 is essential in managing both normal cellular proliferation and differentiation.
Pathways
ZNHIT3 participates in pathways related to chromosomal architecture and gene expression regulation including the chromatin modification and transcription regulation pathways. It associates with notable proteins such as BRG1 and SMARCA4 within these pathways. These interactions facilitate remodeling of nucleosome structures influencing accessibility to transcription factors and transcription machinery ensuring proper expression of genetic information.
일반 정보
Subcellular localisation
Nucleus
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com